| A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder (NCT06796868) | Beijing Greatway Pharmaceutical Technology Co.,Ltd. | 2022-07-07 |
| Single Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets (NCT05417087) | Seasons Biotechnology (Taizhou) Co., Ltd. | 2022-06-27 |
| Group Acceptance and Commitment Therapy (ACT) Among Depressive Patients in Kelantan, Malaysia (NCT06710912) | Universiti Sains Malaysia | 2022-06-01 |
| Integral Cognitive Remediation for Depression (NCT07014683) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2021-09-19 |
| Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression (NCT05018013) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-08-21 |
| Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment (NCT07164287) | University Hospital, Geneva | 2020-06-01 |
| Preventing Relapse After Successful Electroconvulsive Therapy for Depression (NCT06751875) | Universiteit Antwerpen | 2019-07-26 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease (NCT04031469) | ProgenaBiome | 2019-07-11 |
| Efficacy of Clinical Application of Transcranial Low Intensity Focused Ultrasonic Stimulation for Patients With Major Deperessive Disorder - Exploratory Clinical Trial (NCT04405791) | Gangnam Severance Hospital | 2019-06-12 |
| A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD) (NCT04853407) | Luye Pharma Group Ltd. | 2018-12-05 |
| A Study in Patients With Major Depressive Disorder (NCT03642964) | Chase Therapeutics Corporation | 2018-09-10 |
| Scopolamine in Healthy Volunteers (NCT03874130) | Repurposed Therapeutics, Inc. | 2018-08-01 |
| Cognitive Effects Associated With Hippocampal Neurogenesis Induced by ECT in the Treatment of Depression (NCT06661616) | Centre Hospitalier St Anne | 2018-06-06 |
| Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD) (NCT03012724) | Brainsway | 2017-03-30 |
| Comparison of Yuxintine With Placebo in Treatment of MDD (NCT02395263) | Shanghai Mental Health Center | 2015-03-01 |
| Comparison of Anyu Peibo With Placebo in Treatment of MDD (NCT02380066) | Shanghai Mental Health Center | 2015-03-01 |
| Comparison of Orcinoside With Placebo in Treatment of MDD (NCT02191384) | Shanghai Mental Health Center | 2014-07-01 |
| Genomics Used to Improve DEpression Decisions (NCT02109939) | Assurex Health Inc. | 2014-04-01 |
| Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD) (NCT01483053) | Baker Heart and Diabetes Institute | 2014-01-01 |
| Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy (NCT02012218) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-11-01 |
| Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD) (NCT01912196) | MSI Methylation Sciences, Inc. | 2013-10-01 |
| An Investigation of Early Life Stress and Depression (NCT01701258) | Mclean Hospital | 2013-08-01 |
| Improving Depression Outcome by Enhancing Memory for Cognitive Therapy (NCT01790919) | University of California, Berkeley | 2013-02-01 |
| Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone (NCT02015546) | Duke University | 2012-12-01 |
| The Effects of Dopamine on Reward Processing (NCT01253421) | Mclean Hospital | 2012-02-01 |
| Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders (NCT01477203) | Medical University of Vienna | 2011-11-01 |
| A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment (NCT01187407) | Eli Lilly and Company | 2011-03-01 |
| To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) (NCT01123707) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-11-18 |
| Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) (NCT01111565) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-10-04 |
| Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) (NCT01111552) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-07-29 |
| Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) (NCT01111539) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-07-13 |
| Light, Ion, and Fluoxetine Efficacy (LIFE) in Depression (NCT00958204) | University of British Columbia | 2009-10-01 |
| A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder (NCT00960986) | Eli Lilly and Company | 2009-08-01 |
| Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD) (NCT00839176) | Rexahn Pharmaceuticals, Inc. | 2009-01-01 |
| Retrospective TMS Therapy for Adults With MDD (NCT05541302) | Neuronetics | 2008-11-01 |
| Optimization of IV Ketamine for Treatment Resistant Depression (NCT00768430) | Baylor College of Medicine | 2008-11-01 |
| The WORKER Study: Escitalopram and Telephone-based Cognitive Behaviour Therapy (CBT) for Depressed Working People (NCT00702598) | University of British Columbia | 2008-06-01 |
| Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major Depression (NCT01683019) | Wave Neuroscience | 2008-06-01 |
| Patient Tolerability Study of GSK163090 (NCT00559299) | GlaxoSmithKline | 2007-11-01 |
| A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder (NCT00448292) | Epix Pharmaceuticals, Inc. | 2007-03-01 |
| A Local Register Study For Major Depression Of Paroxetine Controlled Release (NCT00368303) | GlaxoSmithKline | 2006-12-01 |
| Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder (NCT00411242) | Novartis | 2006-12-01 |
| Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan (NCT00330616) | GlaxoSmithKline | 2006-05-01 |
| Study Of GW679769 In Major Depressive Disorder (NCT00102492) | GlaxoSmithKline | 2004-10-01 |
| Sexual Functioning Study With Antidepressants (NCT00316160) | GlaxoSmithKline | 2004-09-01 |
| Lethargic Depression Study (NCT00064467) | GlaxoSmithKline | 2003-06-01 |
| Depression Study In Elderly Patients (NCT00067444) | GlaxoSmithKline | 2003-06-01 |
| Effects of Antidepressants on Sexual Functioning (NCT00051259) | GlaxoSmithKline | 2003-01-01 |
| Effects Of Antidepressants On Sexual Functioning In Adults (NCT00051272) | GlaxoSmithKline | 2003-01-01 |